Kudo Norio, Kumagai Keigo, Tomishige Nario, Yamaji Toshiyuki, Wakatsuki Soichi, Nishijima Masahiro, Hanada Kentaro, Kato Ryuichi
Structural Biology Research Center, Photon Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801, Japan.
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):488-93. doi: 10.1073/pnas.0709191105. Epub 2008 Jan 9.
In mammalian cells, ceramide is synthesized in the endoplasmic reticulum and transferred to the Golgi apparatus for conversion to sphingomyelin. Ceramide transport occurs in a nonvesicular manner and is mediated by CERT, a cytosolic 68-kDa protein with a C-terminal steroidogenic acute regulatory protein-related lipid transfer (START) domain. The CERT START domain efficiently transfers natural D-erythro-C16-ceramide, but not lipids with longer (C20) amide-acyl chains. The molecular mechanisms of ceramide specificity, both stereo-specific recognition and length limit, are not well understood. Here we report the crystal structures of the CERT START domain in its apo-form and in complex with ceramides having different acyl chain lengths. In these complex structures, one ceramide molecule is buried in a long amphiphilic cavity. At the far end of the cavity, the amide and hydroxyl groups of ceramide form a hydrogen bond network with specific amino acid residues that play key roles in stereo-specific ceramide recognition. At the head of the ceramide molecule, there is no extra space to accommodate additional bulky groups. The two aliphatic chains of ceramide are surrounded by the hydrophobic wall of the cavity, whose size and shape dictate the length limit for cognate ceramides. Furthermore, local high-crystallographic B-factors suggest that the alpha-3 and the Omega1 loop might work as a gate to incorporate the ceramide into the cavity. Thus, the structures demonstrate the structural basis for the mechanism by which CERT can distinguish ceramide from other lipid types yet still recognize multiple species of ceramides.
在哺乳动物细胞中,神经酰胺在内质网中合成,然后转移至高尔基体转化为鞘磷脂。神经酰胺的转运以非囊泡方式进行,由CERT介导,CERT是一种胞质68 kDa蛋白,具有C端类固醇生成急性调节蛋白相关脂质转移(START)结构域。CERT的START结构域能有效转运天然D-赤藓糖型C16-神经酰胺,但不能转运具有更长(C20)酰胺酰基链的脂质。神经酰胺特异性的分子机制,包括立体特异性识别和长度限制,目前尚不清楚。在此,我们报道了CERT START结构域的无配体形式以及与具有不同酰基链长度的神经酰胺形成复合物的晶体结构。在这些复合物结构中,一个神经酰胺分子埋于一个长的两亲性腔中。在腔的远端,神经酰胺的酰胺基和羟基与特定氨基酸残基形成氢键网络,这些氨基酸残基在立体特异性神经酰胺识别中起关键作用。在神经酰胺分子的头部,没有额外空间容纳其他庞大基团。神经酰胺的两条脂肪链被腔的疏水壁包围,疏水壁的大小和形状决定了同源神经酰胺的长度限制。此外,局部高晶体学B因子表明,α-3和Ω1环可能作为一个门,将神经酰胺纳入腔中。因此,这些结构展示了CERT能够区分神经酰胺与其他脂质类型但仍能识别多种神经酰胺的机制的结构基础。